Header Logo

John Stock

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Raloxifene Hydrochloride
12
2013
18
1.700
 Why?
Osteoporosis, Postmenopausal
12
2013
48
1.480
 Why?
Bone Density Conservation Agents
6
2013
44
0.990
 Why?
Selective Estrogen Receptor Modulators
8
2010
17
0.760
 Why?
Fractures, Bone
7
2010
143
0.740
 Why?
Alendronate
5
2013
14
0.720
 Why?
Spinal Fractures
5
2008
36
0.580
 Why?
Bone Density
8
2013
134
0.420
 Why?
Osteoporosis
3
2008
106
0.330
 Why?
Cardiovascular Diseases
3
2008
834
0.230
 Why?
Breast Neoplasms
5
2013
1195
0.210
 Why?
Double-Blind Method
5
2008
738
0.190
 Why?
Estrogen Replacement Therapy
3
2006
81
0.160
 Why?
Femur Neck
3
2005
12
0.130
 Why?
Diphosphonates
3
2010
32
0.120
 Why?
Middle Aged
10
2013
17559
0.100
 Why?
Absorptiometry, Photon
2
2005
76
0.100
 Why?
Aged
10
2013
14398
0.100
 Why?
Osteoporotic Fractures
1
2013
34
0.100
 Why?
Female
14
2013
32803
0.100
 Why?
Treatment Outcome
5
2010
5659
0.090
 Why?
Thiophenes
1
2010
29
0.080
 Why?
Risk
3
2008
377
0.080
 Why?
Piperidines
1
2010
63
0.080
 Why?
Humans
16
2013
63309
0.080
 Why?
Mortality
1
2010
160
0.080
 Why?
Lumbar Vertebrae
3
2005
160
0.070
 Why?
Postmenopause
4
2010
237
0.070
 Why?
Safety
1
2006
145
0.060
 Why?
Calcitonin
2
2004
17
0.060
 Why?
Venous Thrombosis
1
2006
115
0.060
 Why?
Clinical Trials as Topic
1
2008
455
0.060
 Why?
Risk Reduction Behavior
1
2005
121
0.060
 Why?
Randomized Controlled Trials as Topic
3
2004
769
0.060
 Why?
Decision Support Techniques
1
2006
196
0.060
 Why?
Vitamin D
2
2004
140
0.050
 Why?
Bone and Bones
1
2005
139
0.050
 Why?
Cerebrovascular Disorders
1
2004
81
0.050
 Why?
Follow-Up Studies
2
2010
2457
0.050
 Why?
Hip Fractures
1
2004
77
0.050
 Why?
Calcium
2
2004
573
0.050
 Why?
Estrogen Receptor Modulators
1
2002
8
0.050
 Why?
Medical Records
1
2002
137
0.040
 Why?
Logistic Models
1
2004
1274
0.040
 Why?
Health Care Surveys
1
2002
286
0.040
 Why?
Aged, 80 and over
2
2010
5452
0.040
 Why?
Research Design
1
2002
573
0.040
 Why?
Placebos
2
2010
72
0.040
 Why?
Incidence
2
2008
1376
0.020
 Why?
Bone Resorption
1
2010
42
0.020
 Why?
Women's Health
1
2013
370
0.020
 Why?
Comorbidity
1
2013
1123
0.020
 Why?
Adult
1
2004
16792
0.020
 Why?
Cohort Studies
1
2013
2569
0.020
 Why?
Coronary Disease
1
2008
246
0.020
 Why?
Time Factors
2
2005
3763
0.020
 Why?
Femoral Neck Fractures
1
2005
11
0.010
 Why?
Poisson Distribution
1
2005
53
0.010
 Why?
United States
2
2013
7827
0.010
 Why?
Bone Remodeling
1
2005
25
0.010
 Why?
Fracture Healing
1
2005
26
0.010
 Why?
Cost-Benefit Analysis
1
2006
311
0.010
 Why?
Multicenter Studies as Topic
1
2004
149
0.010
 Why?
Age Distribution
1
2004
259
0.010
 Why?
Hormones
1
2004
60
0.010
 Why?
Population Surveillance
1
2004
206
0.010
 Why?
Estrogens
1
2004
116
0.010
 Why?
Proportional Hazards Models
1
2005
729
0.010
 Why?
Global Health
1
2004
183
0.010
 Why?
Risk Factors
2
2004
5345
0.010
 Why?
Disease Notification
1
2002
5
0.010
 Why?
Patient Selection
1
2004
488
0.010
 Why?
Reference Values
1
2002
335
0.010
 Why?
Guidelines as Topic
1
2002
158
0.010
 Why?
Mass Screening
1
2006
693
0.010
 Why?
Retrospective Studies
1
2013
6641
0.010
 Why?
Prevalence
1
2004
1380
0.010
 Why?
Biomarkers
1
2004
1397
0.010
 Why?
Prospective Studies
1
2004
3284
0.010
 Why?
Surveys and Questionnaires
1
2002
2674
0.010
 Why?
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_